A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

NCT05420545 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chongqing Precision Biotech Co., Ltd